Profound Medical
PROF
About: Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Employees: 142
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
0% more capital invested
Capital invested by funds: $73.6M [Q1] → $73.7M (+$8.44K) [Q2]
1.19% less ownership
Funds ownership: 42.73% [Q1] → 41.54% (-1.19%) [Q2]
10% less funds holding
Funds holding: 49 [Q1] → 44 (-5) [Q2]
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
93% less call options, than puts
Call options by funds: $3K | Put options by funds: $40K
Financial journalist opinion
Based on 3 articles about PROF published over the past 30 days
